Screener
Boston Scientific BSX Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 69.9%+1.7pp | 69.2%+0.5pp | 69%+0.4pp | 68.6%-0.4pp | 68.3%-0.7pp | |
| Operating margin | 19.8%+2.8pp | 18.4%+2.2pp | 18%+2.5pp | 17.9%+2.1pp | 17%+0.8pp | |
| Net margin | 17.5%+4.0pp | 17.3%+5.7pp | 14.4%+3.4pp | 14.4%+3.2pp | 13.5%+1.5pp | |
| Valuation | ||||||
| Market capitalization | $69.46B-56.1% | $93.26B-37.5% | $141.35B+7.4% | $144.66B+17.2% | $154.04B+36.1% | |
| Price / earnings | 18.9×-44.4× | 26.2×-47.5× | 48.9×-22.5× | 52×-17.1× | 61.7×-0.4× | |
| Price / sales | 3.3×-5.3× | 4.5×-4.0× | 7×-0.8× | 7.5×-0.3× | 8.3×+0.9× |
FAQ
- What are Boston Scientific's profit margins?
- Boston Scientific (BSX) runs a 69.9% gross margin and a 19.8% operating margin, with a 17.5% net margin.
- Where do Boston Scientific's ratios come from?
- Every ratio is computed from Boston Scientific's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
